How to investigate levels of Adherence to antiretroviral ... - INRUD

Appendix 4
Report template
Table 4. Non-ARV key medicines that should be in stock in all facilities
1 Cotrimoxazole tab 480 or 960 mg
2 Cotrimoxazole susp 240 mg/5 ml
3 Fluconazole tab 150 or 200 mg
4 Miconazole gel
5 Erythromycin tab 250 or 500 mg
6 Nystatin oral drops 10,000 IU/ml
7 Aciclovir 200 mg
8 Aciclovir cream
9 Folic acid 5 mg
10
[Select the table above with a right click, select update link.]
Exit Interviews
The intention was to do 30 exit interviews per facility, with the main indicator being a selfreport
on adherence in recent days. At the same time, team members collected information
on other factors affecting adherence, such as the time spent getting to clinic, time spent in
clinic, whether medicines are accurately labelled, and whether the patient knows how to
take the medicine correctly. All questions were practiced in the various languages from the
different regions. The definition of ‚properly labelled‛ included each medicine being in
separate container or envelope with the medicine name, dose per time, and number of times
per day written on it.
To manage the exit interviews with the patients on ARV, when the patient went to collect
their medication the pharmacist or dispenser asked them to attend an interview, provided
they had not started on that exact day.
Retrospective Record Review
The aim was to sample 100 records from patients attending for ART during the month seven
months before the month of data collection. The main purposes of the retrospective record
review were to:
Monitor dispensing
Follow dispensing over six months (183 days), starting from the month seven months
before the month of data collection. See if there are any gaps in treatment of more than
30 days and to see if the patient is still in treatment at the end of the period.
133